One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to force health insurers ...

The overlapping symptoms of long Covid and persistent Lyme challenge patients and doctors alike. Researchers are seeking ...

Published in BMJ Open Sport and Exercise, the study looked at athletes with spinal cord injuries to better understand ...

Summit’s lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in ...

Michelle C. Werner agonized over whether the gene therapy treatment Elevidys was right for her teenage son. But to him, the ...

Blood tests set to norms based on the physiology of white men can lead to misdiagnosis and unnecessary health scares for ...

As of Friday, all that was known about the Missouri case was that the individual was infected with an H5 virus. The CDC was ...

In a historic first, a therapy developed by Summit Therapeutics beat Merck blockbuster Keytruda in late-stage lung cancer ...

Neumann is director of the Center for the Evaluation of Value and Risk (CEVR) at Tufts Medical Center. Crummer is a research assistant at CEVR. Kaltenboeck is a principal and head of prescription ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with ...